Skip to main content

Advertisement

SpringerLink
Log in

Epigenetic inactivation of SOX1 promotes cell migration in lung cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

SOX1 is epigenetically inactivated in hepatocellular carcinoma. However, the expression and methylation status of SOX1 in non-small cell lung cancer (NSCLC) remains unknown. The aim of the current study was to investigate whether the promoter hypermethylation of SOX1 is involved in human lung carcinogenesis. We first detected the expression of SOX1 protein in a tissue microarray (TMA) of primary NSCLC and adjacent normal lung tissue specimens using immunohistochemical staining with a specific anti-SOX1 antibody. Methylation of the promoter region of SOX1 in lung cancer tissues was determined by bisulfite sequencing PCR (BSP). In the present study, we found that the SOX1 promoter was fully or partially methylated in 40 of 60 (66.7 %) tumor tissues but not in the majority 15 of 60 (25 %) of normal tissues. A statistically significant inverse association was found between SOX1 methylation status and expression of the SOX1 in tumor tissues (P = 0.003). We further demonstrate that restoration of SOX1 inhibited cell migration by regulating actin cytoskeletal remodeling. Our results suggest that SOX1 is epigenetically silenced in the majority of NSCLC and restoration of SOX1 inhibited cell migration by regulating actin cytoskeletal remodeling in NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Kan L, Israsena N, Zhang Z, Hu M, Zhao LR, Jalali A, et al. Sox1 acts through multiple independent pathways to promote neurogenesis. Dev Biol. 2004;269(2):580–94.

    Article  CAS  PubMed  Google Scholar 

  2. Shih YL, Hsieh CB, Yan MD, Tsao CM, Hsieh TY, Liu CH, et al. Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma. J Gastroenterol Hepatol. 2013;28(3):551–9.

    Article  CAS  PubMed  Google Scholar 

  3. Tsao CM, Yan MD, Shih YL, Yu PN, Kuo CC, Lin WC, et al. SOX1 functions as a tumor suppressor by antagonizing the WNT/beta-catenin signaling pathway in hepatocellular carcinoma. Hepatol Baltimore Md. 2012;56(6):2277–87.

    Article  CAS  Google Scholar 

  4. Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, et al. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer. 2008;123(1):161–7.

    Article  CAS  PubMed  Google Scholar 

  5. Su HY, Lai HC, Lin YW, Chou YC, Liu CY, Yu MH. An epigenetic marker panel for screening and prognostic prediction of ovarian cancer. Int J Cancer. 2009;124(2):387–93.

    Article  CAS  PubMed  Google Scholar 

  6. Li N, Li X, Li S, Zhou S, Zhou Q. Cisplatin-induced downregulation of SOX1 increases drug resistance by activating autophagy in non-small cell lung cancer cell. Biochem Biophys Res Commun. 2013;439(2):187–90.

    Article  CAS  PubMed  Google Scholar 

  7. Pu J, Mao Y, Lei X, Yan Y, Lu X, Tian J, et al. FERM domain containing protein 7 interacts with the Rho GDP dissociation inhibitor and specifically activates Rac1 signaling. PLoS One. 2013;8(8):e73108.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Koga T, Takeshita M, Yano T, Maehara Y, Sueishi K. CHFR hypermethylation and EGFR mutation are mutually exclusive and exhibit contrastive clinical backgrounds and outcomes in non-small cell lung cancer. Int J Cancer. 2011;128(5):1009–17.

    Article  CAS  PubMed  Google Scholar 

  9. Hong KM, Yang SH, Chowdhuri SR, Player A, Hames M, Fukuoka J, et al. Inactivation of LLC1 gene in nonsmall cell lung cancer. Int J Cancer. 2007;120(11):2353–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lin YW, Tsao CM, Yu PN, Shih YL, Lin CH, Yan MD. SOX1 suppresses cell growth and invasion in cervical cancer. Gynecol Oncol. 2013;131(1):174–81.

    Article  CAS  PubMed  Google Scholar 

  11. Gardberg M, Kaipio K, Lehtinen L, Mikkonen P, Heuser VD, Talvinen K, et al. FHOD1, a formin upregulated in epithelial-mesenchymal transition, participates in cancer cell migration and invasion. PLoS One. 2013;8(9):e74923.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Wilson AL, Schrecengost RS, Guerrero MS, Thomas KS, Bouton AH. Breast cancer antiestrogen resistance 3 (BCAR3) promotes cell motility by regulating actin cytoskeletal and adhesion remodeling in invasive breast cancer cells. PLoS One. 2013;8(6):e65678.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ridley AJ. Life at the leading edge. Cell. 2011;145(7):1012–22.

    Article  CAS  PubMed  Google Scholar 

  14. Valderrama F, Thevapala S, Ridley AJ. Radixin regulates cell migration and cell-cell adhesion through Rac1. J Cell Sci. 2012;125(Pt 14):3310–9.

    Article  CAS  PubMed  Google Scholar 

  15. Schlunck G, Damke H, Kiosses WB, Rusk N, Symons MH, Waterman-Storer CM, et al. Modulation of Rac localization and function by dynamin. Mol Biol Cell. 2004;15(1):256–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Respiratory Medicine, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Renmin Road 19, Zhengzhou, 450000, China

    Ning Li & Suyun Li

Authors
  1. Ning Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suyun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ning Li.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, N., Li, S. Epigenetic inactivation of SOX1 promotes cell migration in lung cancer. Tumor Biol. 36, 4603–4610 (2015). https://doi.org/10.1007/s13277-015-3107-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3107-x

Keywords

Search

Navigation